NasdaqGM - Delayed Quote USD

STAAR Surgical Company (STAA)

42.70 +0.08 (+0.19%)
At close: May 17 at 4:00 PM EDT
42.36 -0.34 (-0.80%)
After hours: May 17 at 7:30 PM EDT
Loading Chart for STAA
DELL
  • Previous Close 42.62
  • Open 42.82
  • Bid 42.67 x 100
  • Ask 42.80 x 100
  • Day's Range 42.06 - 43.71
  • 52 Week Range 26.66 - 65.06
  • Volume 318,669
  • Avg. Volume 686,179
  • Market Cap (intraday) 2.098B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 137.74
  • EPS (TTM) 0.31
  • Earnings Date Jul 31, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 51.50

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

www.staar.com

1,056

Full Time Employees

December 29

Fiscal Year Ends

Recent News: STAA

Performance Overview: STAA

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STAA
36.82%
S&P 500
11.18%

1-Year Return

STAA
30.94%
S&P 500
29.04%

3-Year Return

STAA
61.42%
S&P 500
27.06%

5-Year Return

STAA
70.80%
S&P 500
84.38%

Compare To: STAA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STAA

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    2.10B

  • Enterprise Value

    1.89B

  • Trailing P/E

    137.74

  • Forward P/E

    131.58

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.45

  • Price/Book (mrq)

    5.34

  • Enterprise Value/Revenue

    5.79

  • Enterprise Value/EBITDA

    66.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.69%

  • Return on Assets (ttm)

    3.38%

  • Return on Equity (ttm)

    4.18%

  • Revenue (ttm)

    326.24M

  • Net Income Avi to Common (ttm)

    15.3M

  • Diluted EPS (ttm)

    0.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.15M

  • Total Debt/Equity (mrq)

    9.09%

  • Levered Free Cash Flow (ttm)

    27.15M

Research Analysis: STAA

Company Insights: STAA

Research Reports: STAA

People Also Watch